Mary Jo Buffo

2.2k total citations · 1 hit paper
23 papers, 1.8k citations indexed

About

Mary Jo Buffo is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mary Jo Buffo has authored 23 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Mary Jo Buffo's work include Immunotherapy and Immune Responses (8 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Mary Jo Buffo is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Mary Jo Buffo collaborates with scholars based in United States, Poland and Germany. Mary Jo Buffo's co-authors include С. Н. Быковская, Michael J. Anderson, De Yang, O. M. Zack Howard, Oleg Chertov, Jens‐Michael Schröder, Joost J. Oppenheim, Anthony N. Wakim, Dennis R. Burholt and J P Okunewick and has published in prestigious journals such as Science, Cancer and The Journal of Infectious Diseases.

In The Last Decade

Mary Jo Buffo

19 papers receiving 1.8k citations

Hit Papers

β-Defensins: Linking Innate and Adaptive Immunity Through... 1999 2026 2008 2017 1999 400 800 1.2k

Peers

Mary Jo Buffo
Comparison fields: 5 of 102
  • Immunology 998
  • Microbiology 982
  • Molecular Biology 516
  • Emergency Medical Services 211
  • Oncology 174
RI Lehrer United States
С. Н. Быковская Russia
Gregor S. D. Reid Canada
Wendy W. J. Unger Netherlands
Rose Linzmeier United States
Mabel Pang United States
Linda L. Perry United States
Fabienne Anjuère France
Florian Heil Germany
José-Ignacio Rodríguez-Barbosa Spain
RI Lehrer United States View profile →
Citations per field, relative to Mary Jo Buffo
Mary Jo Buffo · 1×
Citations per year, relative to Mary Jo Buffo
Mary Jo Buffo · 1×

Countries citing papers authored by Mary Jo Buffo

Since Specialization
Citations

This map shows the geographic impact of Mary Jo Buffo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jo Buffo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jo Buffo more than expected).

Fields of papers citing papers by Mary Jo Buffo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Jo Buffo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jo Buffo. The network helps show where Mary Jo Buffo may publish in the future.

Co-authorship network of co-authors of Mary Jo Buffo

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Jo Buffo. A scholar is included among the top collaborators of Mary Jo Buffo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Jo Buffo. Mary Jo Buffo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Serum Arginase−1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness OncoImmunology Juraj Adamik, Hongzhi Wang et al. 0
2 Impact of contracted manufacturing organization protocols on operations in an aca demically based Current Good Manufacturing Practice facility Cytotherapy Mary Jo Buffo, Theresa L. Whiteside et al. 3
3 Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1–Infected Apoptotic Cells The Journal of Infectious Diseases Bernard Macatangay, Sharon A. Riddler et al. 38
4 Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay Methods in molecular biology Lisa H. Butterfield, Mary Jo Buffo 7
5 β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 breakdown → Science De Yang, Oleg Chertov et al. 1463
6 The generation of human dendritic and NK cells from hemopoietic progenitors induced by interleukin-15 Journal of Leukocyte Biology С. Н. Быковская, Mary Jo Buffo et al. 23
7 NEUTROPHIL GRANULE PEPTIDES DEFENSINS INDUCE DEVELOPMENT OF MATURE DENDRITIC CELLD FROM HUMAN CD34+ STEM CELLS Journal of Immunotherapy С. Н. Быковская, Mark Bunker et al. 3
8 Interleukin-2 induces development of dendritic cells from cord blood CD34+ cells Journal of Leukocyte Biology Mary Jo Buffo, Mark Bunker et al. 22
9 Evidence for a possible role of Asialo-GM1-positive cells in the graft-versus-leukemia repression of a murine type-C retroviral leukemia. PubMed J P Okunewick, Mary Jo Buffo et al. 18
10 Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation. PubMed J P Okunewick, Mary Jo Buffo et al. 7
11 Thyroid hormones in human follicular fluid and thyroid hormone receptors in human granulosa cells Fertility and Sterility Anthony N. Wakim, Mary Jo Buffo et al. 130
12 Expression of membrane-associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells Cancer Hernan F. Acevedo, Alexander Krichevsky et al. 35
13 Flow cytometry method for the analysis of membrane-associated human chorionic gonadotropin, its subunits, and fragments on human cancer cells Cancer Hernan F. Acevedo, Alexander Krichevsky et al. 21
14 Comparative Hematopoietic Toxicity of Doxorubicin and 4'-Epirubicin Experimental Biology and Medicine J P Okunewick, Mary Jo Buffo et al. 8
15 Effect of cyclophosphamide on Friend virus leukemogenesis in virus-sensitive and virus-resistant mice. PubMed Radmila B. Raikow, J P Okunewick et al. 2
16 Effects of Benzo(a)Pyrene on Friend Viral Leukemogenesis in B10SJF1 Mice Experimental Biology and Medicine Radmila B. Raikow, J P Okunewick et al. 1
17 Potentiation of Friend Viral Leukemogenesis by 9,10-Dimethyl-1,2-benzanthracene in Two Strains of Mice Experimental Biology and Medicine Radmila B. Raikow, J P Okunewick et al. 0
18 Effect of benzo[a]pyrene on friend virus leukemogenesis, CFU-S viability, and induction of humoral immunity Cellular and Molecular Life Sciences Radmila B. Raikow, J P Okunewick et al. 1
19 Possibility of three distinct and separable components to fatal graft-vs-host reaction. PubMed J P Okunewick, Ruby F. Meredith et al. 5
20 Potentiating effect of Benzo[a]pyrene and caffeine on Friend viral leukemogenesis Carcinogenesis Radmila B. Raikow, J P Okunewick et al. 3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026